Article info

0268: Topoisomerase I (Top1) Amplifications and Deletions As a Predective Marker for Chemotherapy with Topotecan in Women with Advanced Ovarian Cancer (Oc)

Authors

Citation

Spahn-Horn S, Ejlertsen B, Engelholm SA, et al
0268: Topoisomerase I (Top1) Amplifications and Deletions As a Predective Marker for Chemotherapy with Topotecan in Women with Advanced Ovarian Cancer (Oc)
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.